Surgical ventricular restoration combined with mitral valve procedure for endstage ischemic cardiomyopathy

Hisayoshi Suma1, Hiroaki Tanabe, Tokuhisa Uejima

  • 1The Cardiovascular Institute, 7-3-10 Roppongi, Minato-ku, Tokyo 106-0032, Japan. sumah@cvi.or.jp

Insights

Combined mitral and left ventricular reconstruction effectively treats advanced ischemic heart failure with dilated left ventricles and mitral regurgitation, improving survival and heart function.

Area of Science:

  • Cardiovascular Surgery
  • Heart Failure Management
  • Cardiac Reconstruction

Background:

  • Dilated left ventricle with mitral regurgitation signifies severe chronic ischemic heart failure.
  • Optimal surgical strategies for these complex cases remain a focus of research.

Purpose of the Study:

  • To evaluate the 7-year experience with combined mitral valve and left ventricular reconstruction.
  • To assess the efficacy and outcomes of this combined approach in advanced heart failure patients.

Main Methods:

  • Retrospective analysis of 76 patients with advanced heart failure due to dilated ischemic cardiomyopathy and mitral regurgitation.
  • Procedures included mitral reconstruction (repair or replacement) and left ventriculoplasty (Dor, SAVE, PLV) combined with coronary artery bypass grafting (CABG).

Main Results:

  • Operative mortality was 7.9%, with lower rates in elective cases.
  • Significant improvements observed in ejection fraction (24.9% to 33.3%) and cardiac index (2.0 to 2.6 L/min/m²).
  • Reduced ventricular volumes and improved NYHA class (3.5 to 1.4) in survivors; 5-year survival rate was 67.7%.

Conclusions:

  • Combined mitral and left ventricular reconstruction is an effective treatment for end-stage ischemic cardiomyopathy.
  • The procedure significantly improves cardiac function and clinical status in patients with dilated left ventricle and mitral regurgitation.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...